NO20030515L - Fremgangsmåte for fremstilling av dinapsolin - Google Patents
Fremgangsmåte for fremstilling av dinapsolinInfo
- Publication number
- NO20030515L NO20030515L NO20030515A NO20030515A NO20030515L NO 20030515 L NO20030515 L NO 20030515L NO 20030515 A NO20030515 A NO 20030515A NO 20030515 A NO20030515 A NO 20030515A NO 20030515 L NO20030515 L NO 20030515L
- Authority
- NO
- Norway
- Prior art keywords
- dinapsoline
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/18—Ring systems of four or more rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22496800P | 2000-08-11 | 2000-08-11 | |
PCT/US2001/025265 WO2002013827A1 (en) | 2000-08-11 | 2001-08-10 | Process for the preparation of dinapsoline |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20030515D0 NO20030515D0 (no) | 2003-02-03 |
NO20030515L true NO20030515L (no) | 2003-03-31 |
Family
ID=22842980
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20030515A NO20030515L (no) | 2000-08-11 | 2003-02-03 | Fremgangsmåte for fremstilling av dinapsolin |
Country Status (12)
Country | Link |
---|---|
US (1) | US6645975B1 (xx) |
EP (1) | EP1320367A4 (xx) |
JP (1) | JP2004506014A (xx) |
KR (1) | KR20030027020A (xx) |
CN (1) | CN1473045A (xx) |
AU (2) | AU8824201A (xx) |
BR (1) | BR0113170A (xx) |
CA (1) | CA2417807A1 (xx) |
MX (1) | MXPA03001272A (xx) |
NO (1) | NO20030515L (xx) |
NZ (1) | NZ524212A (xx) |
WO (1) | WO2002013827A1 (xx) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7091212B2 (en) | 2001-08-10 | 2006-08-15 | Purdue Research Foundation | Chiral dinapsoline |
FR3017868A1 (fr) * | 2014-02-21 | 2015-08-28 | Servier Lab | Derives d'isoquinoleine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
BR112019014981A2 (pt) | 2017-11-24 | 2020-04-07 | H Lundbeck As | composto, sal farmaceuticamente aceitável, uso dos mesmos e composição farmacêutica |
US11104697B2 (en) | 2019-05-20 | 2021-08-31 | H. Lundbeck A/S | Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1- propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid |
US11168056B2 (en) | 2019-05-20 | 2021-11-09 | H. Lundbeck A/S | Process for the manufacturing of (6aR,10aR)-7-propyl-6,6a,7,8,9,10,10a,11-octahydro-[1,3]dioxolo[4′,5′:5,6]benzo[1,2-G]quinoline and (4aR,10aR)-1-propyl-1,2,3,4,4a,5,10,10a-octahydro-benzo[G]quinoline-6,7-diol |
US11111263B2 (en) | 2019-05-20 | 2021-09-07 | H. Lundbeck A/S | Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid |
US11130775B2 (en) | 2019-05-20 | 2021-09-28 | H. Lundbeck A/S | Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK297275A (da) * | 1974-08-07 | 1976-02-08 | Aspro Nicholas Ltd | Isoquinolinderivater |
CA1033358A (en) * | 1974-09-03 | 1978-06-20 | Ayerst, Mckenna And Harrison Limited | Benzo(4,5)(1,2,3-ij)isoquinolines and process therefor |
IL122974A (en) * | 1995-08-18 | 2000-11-21 | Purdue Research Foundation | Optionally substituted tetrahydro-1H-naph[1,2,3-de]isoquinoline and pharmaceutical compositions containing them |
AU2131697A (en) * | 1996-02-23 | 1997-09-10 | Pharm-Eco Laboratories, Incorporated | Selective D1 dopamine receptor agonists and partial agonists/antagonist |
-
2001
- 2001-08-10 AU AU8824201A patent/AU8824201A/xx active Pending
- 2001-08-10 AU AU2001288242A patent/AU2001288242B2/en not_active Ceased
- 2001-08-10 WO PCT/US2001/025265 patent/WO2002013827A1/en not_active Application Discontinuation
- 2001-08-10 NZ NZ524212A patent/NZ524212A/en unknown
- 2001-08-10 US US10/343,037 patent/US6645975B1/en not_active Expired - Fee Related
- 2001-08-10 CA CA002417807A patent/CA2417807A1/en not_active Abandoned
- 2001-08-10 JP JP2002518970A patent/JP2004506014A/ja not_active Withdrawn
- 2001-08-10 CN CNA018166903A patent/CN1473045A/zh active Pending
- 2001-08-10 EP EP01967963A patent/EP1320367A4/en not_active Withdrawn
- 2001-08-10 BR BR0113170-2A patent/BR0113170A/pt not_active Application Discontinuation
- 2001-08-10 KR KR10-2003-7001975A patent/KR20030027020A/ko not_active Application Discontinuation
- 2001-08-10 MX MXPA03001272A patent/MXPA03001272A/es not_active Application Discontinuation
-
2003
- 2003-02-03 NO NO20030515A patent/NO20030515L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NZ524212A (en) | 2004-07-30 |
EP1320367A4 (en) | 2007-01-17 |
MXPA03001272A (es) | 2004-04-02 |
CN1473045A (zh) | 2004-02-04 |
EP1320367A1 (en) | 2003-06-25 |
JP2004506014A (ja) | 2004-02-26 |
WO2002013827A1 (en) | 2002-02-21 |
AU2001288242B2 (en) | 2005-11-17 |
NO20030515D0 (no) | 2003-02-03 |
BR0113170A (pt) | 2004-01-06 |
CA2417807A1 (en) | 2002-02-21 |
US6645975B1 (en) | 2003-11-11 |
KR20030027020A (ko) | 2003-04-03 |
AU8824201A (en) | 2002-02-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20030012L (no) | Fremgangsmåte for fremstilling av substituerte oktanoylamider | |
CY2007029I2 (el) | Μεθοδος για την παρασκευη υποκατεστημενων οκτανοϋλ-αμιδιων | |
NO20042680L (no) | Fremgangsmater for fremstilling av O-demetylvenflaxine | |
FI20011578A0 (fi) | Menetelmä puhtaan sitalopraamin valmistamiseksi | |
NO20013943L (no) | Fremgangsmate for fremstilling av Citalopram | |
NO20011271A (no) | Fremgangsmåte for fremstilling av ren citalopram | |
NO20040027L (no) | Fremgangsmate for fremstillingen av escitalopram | |
NO20030163L (no) | Fremgangsmate for fremstilling av olefiner | |
NO20032731D0 (no) | Fremgangsmåte for fremstilling av sulfonamid-substituerte imidazotriazinoner | |
NO20035538D0 (no) | Fremgangsmåte for fremstilling av zaleplon | |
NO20031413D0 (no) | Ny fremgangsmåte for fremstilling av oksabispidiner | |
NO20042640L (no) | Fremgangsmate for fremstilling av ekinocandinderivater | |
NO20025423L (no) | Fremgangsmate for fremstilling av Citalopram | |
NO20023445D0 (no) | Fremgangsmåte for fremstilling av peptider | |
NO20026155L (no) | Fremgangsmåte for fremstilling av lavere olefiner | |
NO20021118D0 (no) | Fremgangsmåte for fremstilling av citalopram | |
NO20030515L (no) | Fremgangsmåte for fremstilling av dinapsolin | |
NO20025465L (no) | Fremgangsmåte for fremstilling av bifenylforbindelser | |
NO20024887D0 (no) | Fremgangsmåte for fremstilling av benzokondenserte heterosykliske forbindelser | |
NO20023702D0 (no) | Fremgangsmåte for fremstilling av 5-arylnikotinaldehyder | |
NO20020328D0 (no) | Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol | |
NO20032297L (no) | Fremgangsmåte for fremstilling av distamycinderivater | |
NO20020327D0 (no) | Fremgangsmåte for fremstilling av 2-aminometyl-4-cyano-tiazol | |
NO20025385D0 (no) | FremgangsmÕte for fremstilling av sulfonylbenzoylguanidiniumsalter | |
FI20000535A0 (fi) | Menetelmä kuparin valmistamiseksi |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |